PellePharm, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sol-Gel Hopes To Bring PellePharm’s Pat

Danish dermatology specialist Leo Pharma AS thinks it can leverage tralokinumab to become a global leader in atopic dermatitis, a big ambition given the competition in the space. The interleukin-13

BridgeBio Pharma Inc. is poised to achieve its goal of rapidly bringing treatments for genetic diseases and genetically defined cancers to the market with two different products expected to be submit

Fourth quarter financings for biopharmaceutical start-ups totaled $2.73bn, including Relay Therapeutics 's $400m Series C venture capital round and Cerevel Therapeutics LLC 's $350m Series A round.